Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management
This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (208 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544790904498 |
---|---|
ctrlnum |
(CKB)5680000000037799 (oapen)https://directory.doabooks.org/handle/20.500.12854/80955 (EXLCZ)995680000000037799 |
collection |
bib_alma |
record_format |
marc |
spelling |
Komosinska-Vassev, Katarzyna edt Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (208 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment. English Medicine bicssc pharmacogenomics NGS variants personalized medicine FSHR personalized drug therapy hedgehog-interacting protein impaired fasting glucose impaired glucose tolerance newly diagnosed diabetes normal glucose tolerance inflammatory bowel disease ulcerative colitis Crohn’s disease extracellular matrix components hyaluronan inflammatory bowel diseases (IBD) Crohn’s disease (CD) ulcerative colitis (UC) sulfated glycosaminoglycans (sGAG) hyaluronan (HA) soluble part of syndecan-1 (sCD138) microRNA cardiovascular disease diabetes mortality antiplatelet therapy platelet reactivity Let-7e miR-126 miR-223 miR-125a-3p CCL11 CCL24 CCL26 CCR3 CRC adiponectin adipokines rheumatology obesity overweight case control study rheumatoid arthritis TNF-α inhibitors bone turnover markers PINP PICP NTX-I CTX-I RANKL/OPG ovarian cancer interleukin 21 interleukin 22 lymphocytes macrophages dendritic cells innate lymphoid cells breast cancer extracellular matrix proteins tumorigenesis tumor microenvironment 3-0365-3746-5 3-0365-3745-7 Olczyk, Pawel edt Komosinska-Vassev, Katarzyna oth Olczyk, Pawel oth |
language |
English |
format |
eBook |
author2 |
Olczyk, Pawel Komosinska-Vassev, Katarzyna Olczyk, Pawel |
author_facet |
Olczyk, Pawel Komosinska-Vassev, Katarzyna Olczyk, Pawel |
author2_variant |
k k v kkv p o po |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
spellingShingle |
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
title_full |
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
title_fullStr |
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
title_full_unstemmed |
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
title_auth |
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
title_new |
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
title_sort |
biomarkers for diagnosis, complications and therapy effects in civilization diseases management |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2022 |
physical |
1 electronic resource (208 p.) |
isbn |
3-0365-3746-5 3-0365-3745-7 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT komosinskavassevkatarzyna biomarkersfordiagnosiscomplicationsandtherapyeffectsincivilizationdiseasesmanagement AT olczykpawel biomarkersfordiagnosiscomplicationsandtherapyeffectsincivilizationdiseasesmanagement |
status_str |
n |
ids_txt_mv |
(CKB)5680000000037799 (oapen)https://directory.doabooks.org/handle/20.500.12854/80955 (EXLCZ)995680000000037799 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1802424136395390976 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03375nam-a2201069z--4500</leader><controlfield tag="001">993544790904498</controlfield><controlfield tag="005">20240620152345.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202205s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000037799</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/80955</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000037799</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Komosinska-Vassev, Katarzyna</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (208 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacogenomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NGS variants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FSHR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized drug therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hedgehog-interacting protein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">impaired fasting glucose</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">impaired glucose tolerance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">newly diagnosed diabetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">normal glucose tolerance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammatory bowel disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ulcerative colitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Crohn’s disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extracellular matrix components</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hyaluronan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammatory bowel diseases (IBD)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Crohn’s disease (CD)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ulcerative colitis (UC)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sulfated glycosaminoglycans (sGAG)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hyaluronan (HA)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">soluble part of syndecan-1 (sCD138)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiovascular disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mortality</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiplatelet therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">platelet reactivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Let-7e</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miR-126</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miR-223</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miR-125a-3p</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CCL11</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CCL24</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CCL26</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CCR3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CRC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adiponectin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adipokines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheumatology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">obesity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">overweight</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">case control study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheumatoid arthritis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TNF-α inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bone turnover markers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PINP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PICP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NTX-I</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CTX-I</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RANKL/OPG</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ovarian cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interleukin 21</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interleukin 22</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lymphocytes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">macrophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dendritic cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">innate lymphoid cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extracellular matrix</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumorigenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3746-5</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3745-7</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Olczyk, Pawel</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Komosinska-Vassev, Katarzyna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Olczyk, Pawel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-06-21 00:38:56 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-05-14 21:41:54 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337699830004498&Force_direct=true</subfield><subfield code="Z">5337699830004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337699830004498</subfield></datafield></record></collection> |